Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11,268 GBX | +0.16% | +2.21% | +6.30% |
Apr. 23 | AstraZeneca's Voydeya Approved as Add-on Therapy in Europe for Blood Disorder | MT |
Apr. 23 | ASTRAZENECA : JP Morgan reaffirms its Buy rating | ZD |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- AZN Stock
- Revisions AstraZeneca PLC